Content about Surgery

December 4, 2013

At 42 years old, Gina Libby has lived with chronic pain for more than 20 years. Yet, it hasn't stopped her from making an impact; she's on the front lines of pain advocacy, using her experience to influence healthcare policy and teach others.

At 42 years old, Gina Libby has lived with chronic pain for more than 20 years. Yet, it hasn't stopped her from making an impact; she's on the front lines of pain advocacy, using her experience to influence healthcare policy and teach others.

October 9, 2013

The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

SILVER SPRING, Md. — The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

February 25, 2013

The Food and Drug Administration has approved a new drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the digestive system, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the digestive system, the agency said Monday.

The FDA announced the approval of Stivarga (regorafenib) for gastrointestinal stromal tumors that could not be removed through surgery or had spread to other parts of the body and were no longer responding to treatment with Novartis' Gleevec (imatinib) or Pfizer's Sutent (sunitinib).

February 12, 2013

The Colon Cancer Challenge Foundation, a nonprofit organization dedicated to reducing colorectal cancer incidence and death throughout the United States, presented Sanofi with its annual Blue Star Corporate Award.

NEW YORK — Sanofi US was named corporate partner of the year by the Colon Cancer Challenge Foundation (CCCF), a nonprofit organization dedicated to reducing colorectal cancer incidence and death throughout the United States, and presented with CCCF's annual Blue Star Corporate Award.

December 20, 2012

Walgreens and the Accreditation Association for Ambulatory Health Care announced on Thursday that half of the primary care worksite health centers managed by Walgreens Employer Solutions Group have received Medical Home accreditation, with plans to have all of the company’s employer-based primary care centers accredited in the first half of 2013.

DEERFIELD, Ill. — Walgreens and the Accreditation Association for Ambulatory Health Care announced on Thursday that half of the primary care worksite health centers managed by Walgreens Employer Solutions Group have received Medical Home accreditation, with plans to have all of the company’s employer-based primary care centers accredited in the first half of 2013.

June 4, 2012

An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

WAYNE, N.J. — An experimental drug made by Bayer HealthCare extended the length of time that patients with gastrointestinal tumors survived without their disease getting worse, according to results of a late-stage clinical trial released Monday.

April 12, 2012

Hisamitsu America on Wednesday announced the company shipped a season's supply of their topical pain treatment Salonpas products to Jeremy Lin, the New York Knicks point guard who recently underwent surgery to repair a chronic meniscus tear in his knee and is expected to be off the court for about six weeks.

FLORHAM PARK, N.J. — Hisamitsu America on Wednesday announced the company shipped a season's supply of its topical pain treatment Salonpas products to Jeremy Lin, the New York Knicks point guard who recently underwent surgery to repair a chronic meniscus tear in his knee and is expected to be off the court for about six weeks.

March 19, 2012

Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.

GREENSBORO, N.C. — Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.

Mederma advanced scar gel is a transparent topical gel that contains Cepalin, the same proprietary botanical extract derived from onions used in all Mederma scar products and stretch marks therapy.

February 27, 2012

A division of specialty pharmacy provider The Apothecary Shops has become the exclusive distributor of a drug used in glaucoma surgery, the company said.

PHOENIX — A division of specialty pharmacy provider The Apothecary Shops has become the exclusive distributor of a drug used in glaucoma surgery, the company said.

Apothecary Shop Wholesale has received exclusive distribution rights for Mobius Therapeutics' drug Mitosol (mitomycin), which the Food and Drug Administration approved earlier this month.

February 17, 2012

DRS Health introduced a line of supplements with their doctors on the box, testament to the fact that almost 80% of all doctors recommend the use of supplements.

ATLANTA — DRS Health introduced a line of supplements with their doctors on the box, testament to the fact that almost 80% of all doctors recommend the use of supplements. One of the standout SKUs is the unique H3 Rapid Recovery, a beverage mix formulated to help the body rebuild after surgery, injury or trauma. It’s a supplement with unique tie-in potential at the pharmacy counter with post-surgical medicines and in-line with the braces assortment. Sales of all supplements were up 5.8% for the 52 weeks ended Dec. 24 across food, drug and mass, according to Nielsen.


January 30, 2012

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating the most common type of skin cancer, the agency said Monday.

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

January 26, 2012

DRS Health presented attendees of last week's ECRM Vitamin, Diet & Sports Nutrition EPPS conference with a line of supplements that's not only doctor-recommended but also doctor-developed. All of the product facings feature a picture of the doctor who helped develop the particular formula.

ATLANTA — DRS Health presented attendees of last week's ECRM Vitamin, Diet & Sports Nutrition EPPS conference with a line of supplements that's not only doctor-recommended but also doctor-developed. All of the product facings feature a picture of the doctor who helped develop the particular formula.

December 7, 2011

Aspirin taken within five days before cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, an intensive care unit stay, and even early death (30-day mortality), according to findings from an observational cohort study by researchers at Thomas Jefferson University and the University of California Davis Medical Center that are set to appear in the journal Annals of Surgery.

PHILADELPHIA — Aspirin taken within five days before cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, an intensive care unit stay, and even early death (30-day mortality), according to findings from an observational cohort study by researchers at Thomas Jefferson University and the University of California Davis Medical Center that are set to appear in the journal Annals of Surgery.

November 29, 2011

Botanical Labs on Monday launched a bariatric-focused line of liquid dietary supplements called Wellesse Bariatric Liquid Solutions.

FERNDALE, Wash. — Botanical Labs on Monday launched a bariatric-focused line of liquid dietary supplements called Wellesse Bariatric Liquid Solutions.

According to the company, bariatric surgical treatment is one of the faster growing options to assist with weight loss. Weight-loss surgery patients have special pre- and post-surgery nutritional requirements. Wellesse targets specific nutrient deficiencies within the weight loss surgery community with the same dedication offered to existing consumers.

September 14, 2011

My Girls Cream (formerly known as My Girls Radiation Cream) is now available at select pharmacies, oncology boutiques and post-surgery specialty retailers, the manufacturer announced on Wednesday.

BOSTON — My Girls Cream (formerly known as My Girls Radiation Cream) is now available at select pharmacies, oncology boutiques and post-surgery specialty retailers, the manufacturer announced on Wednesday.

August 11, 2011

It is with great sadness that Drug Store News reports the unexpected passing of ECRM CEO and founder Charlie Bowlus, who has died from complications following emergency surgery three weeks ago.

SARASOTA, Fla. — It is with great sadness that Drug Store News reports the unexpected passing of ECRM CEO and founder Charlie Bowlus, who has died from complications following emergency surgery three weeks ago.

July 7, 2011

LELO has launched a high-end line of Kegel exercisers called Laselle under the Intimina by LELO brand for women with incontinence issues. Such factors as pregnancy, childbirth, aging and obesity can result in the weakening of the pelvic muscles, leading to possible urinary or bowel incontinence.

LELO has launched a high-end line of Kegel exercisers called Laselle under the Intimina by LELO brand for women with incontinence issues. Such factors as pregnancy, childbirth, aging and obesity can result in the weakening of the pelvic muscles, leading to possible urinary or bowel incontinence. A meta-analysis of randomized controlled trials by the Cochrane Collaboration concluded that pelvic exercises should be included in first-line conservative management programs for women with urinary incontinence.

May 31, 2011

The Food and Drug Administration has approved an injectable gel for fecal incontinence, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved an injectable gel for fecal incontinence, the agency said.

The FDA announced the approval of Oceana Therapeutics’ Solesta for patients who have involuntarily lost bowel control and for whom such therapies as diet change, fiber therapy and antimotility medications have failed.

Fecal incontinence affects more than 5.5 million Americans, according to the National Institutes of Health.

May 10, 2011

The Food and Drug Administration will expedite its review of an investigational drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the gastrointestinal tract, the company said Tuesday.

WAYNE, N.J. — The Food and Drug Administration will expedite its review of an investigational drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the gastrointestinal tract, the company said Tuesday.

April 21, 2011

The American Podiatric Medical Association has awarded the APMA seal of acceptance to Performance Health’s Thera-Band First Step to Foot Relief, a first-line treatment plan for heel pain.

AKRON, Ohio — The American Podiatric Medical Association has awarded the APMA seal of acceptance to Performance Health’s Thera-Band First Step to Foot Relief, a first-line treatment plan for heel pain.

The seal is awarded to a product after the Committee on Podiatric Seals, a standing committee of the American Podiatric Medical Association, scientifically evaluates and determines whether the product allows normal foot function and promotes quality foot health.

April 13, 2011

Dr. Fresh, the maker of the FireFly light-up timer toothbrush, has kicked off a Facebook fundraising initiative to raise awareness and funds for the cleft lip and palate charity Smile Train.

BUENA PARK, Calif. — Dr. Fresh, the maker of the FireFly light-up timer toothbrush, has kicked off a Facebook fundraising initiative to raise awareness and funds for the cleft lip and palate charity Smile Train.

As of April 12, the company is donating $1 for every new "like" on FireFly's Facebook page, up to $2,500, to Smile Train. Smile Train provides surgery for children in developing countries suffering from cleft lip and/or palates, a common birth defect, as well as specialized training for medical professionals to make surgery more accessible.

October 19, 2010

CosaminASU was named a preferred joint health supplement in a new book, "FrameWork for the...

EDGEWOOD, Md. CosaminASU was named a preferred joint health supplement in a new book, "FrameWork for the Knee."

“In 'FrameWork for the Knee,' Dr. Nick DiNubile continues to stress the importance of exercise, nutrition and the mind in maintaining health,” said Troy Henderson, VP corporate operations and professional services at Nutramax Labs. “Physicians repeatedly recommended Cosamin products because of their high-quality ingredients and Nutramax Labs's strict adherence to [good manufacturing practices].”

 

October 14, 2010

The American Podiatric Medical Association recently issued a series of recommendations for runners, including the...

BETHESDA, Md. The American Podiatric Medical Association recently issued a series of recommendations for runners, including the use of a self-massager designed for post-athletic activities. Specifically, the association recommended Health Enterprises’ therapeutic hot-and-cold foot massager, a product that carries the APMA seal of approval.

 

August 29, 2010

KidZerts on Sunday announced the introduction of its wear-moldable arch support insoles for children....

SAN DIEGO KidZerts on Sunday announced the introduction of its wear-moldable arch support insoles for children.

 

Features include a moldable sub-layer that slowly will mold to the child’s foot while he or she wears it, an antimicrobial top cover that kills odor-causing bacteria and wicks moisture, a heel cup for stability and alignment, a broad heel seat for additional foot comfort, a beveled forefoot for a smooth transition and a moderate arch for support and alignment.

 

 

January 21, 2010

Dr. Fresh, a maker of personal care products, is donating 50,000 Infectiguard surgical face masks...